Showing results (2431-2440 of 3,086) with videos related to

Sort By:
Pageof 309
Drug Safety|January 10, 2020
Coronary Risks Associated with Diclofenac and Other NSAIDs: An UpdateNicholas Moore
Drug Safety|January 11, 2020
Comparative Assessment of the National Pharmacovigilance Systems in East Africa: Ethiopia, Kenya, Rwanda and TanzaniaAbbie Barry, Sten Olsson, Omary Minzi, et al.
Drug Safety|October 23, 2020
Patient-Reported Adverse Events of Radiopharmaceuticals: A Prospective Study of 1002 PatientsNanno Schreuder, Niels A Jacobs, Pieter L Jager, et al.
Drug Safety|October 23, 2020
Potential Safety Issues with Use of Sodium-Glucose Cotransporter 2 Inhibitors, Particularly in People with Type 2 Diabetes and Chronic Kidney DiseaseTamara Y Milder, Sophie L Stocker, Richard O Day, et al.
Drug Safety|September 14, 2020
The Potential Teratogenicity Alert for Women Conceiving on Dolutegravir-Based Regimens: An Assessment of Risk Communication by an Urban HIV Clinic in Uganda and Choices made by WomenEva Agnes Odongpiny Laker, Arnold Arinaitwe, Noela Owarwo, et al.
Drug Safety|September 11, 2020
Benefit-Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit-Risk Models Applied to VaccinesHugo Arlegui, Kaatje Bollaerts, Francesco Salvo, et al.
Drug Safety|March 18, 2020
Rates and Costs of Dispensing Naloxone to Patients at High Risk for Opioid Overdose in the United States, 2014-2018Rachel E Barenie, Joshua J Gagne, Aaron S Kesselheim, et al.
Drug Safety|March 4, 2020
Identifying Drugs Inducing Prematurity by Mining Claims Data with High-Dimensional Confounder Score StrategiesRomain Demailly, Sylvie Escolano, Françoise Haramburu, et al.
Drug Safety|December 4, 2018
Evaluation of Harm Associated with High Dose-Range Clinical Decision Support Overrides in the Intensive Care UnitAdrian Wong, Christine Rehr, Diane L Seger, et al.
Drug Safety|February 15, 2019
Drug-Induced Steatosis and Steatohepatitis: The Search for Novel Serum Biomarkers Among Potential Biomarkers for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisLauren Pavlik, Arie Regev, Paul A Ardayfio, et al.
Pageof 309